StemCor CE marks MarrowMiner for collecting bone marrow
This article was originally published in Clinica
Executive Summary
StemCor Systems has CE marked its MarrowMiner device for sale in Europe. The minimally-invasive system, used for the collection of bone marrow from the pelvis, received US FDA 510(k) clearance in November 2007 (see Clinica No 1281, p 22). The MarrowMiner is designed to make marrow extraction faster, safer and more comfortable, and is used to collect marrow from healthy donors for transplantation, and from patients to be treated with their own marrow-derived cells. The Menlo Park, California company says it represents the next-generation technology for bone marrow harvesting – it removes marrow through a single entry site without general anaesthesia, unlike conventional methods which remove it via a needle inserted into multiple sites in the hip.